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Epidemiology, Evaluation and 




Congenital anomalies (CA) are the leading cause of infant mortality in the 
USA (Figure 1) [1]. The five most common birth malformations recorded in the 
USA are club foot (1 in 593 births), Down syndrome (1 in 707 births), pulmonic 
stenosis/atresia (1 in 1052 births), cleft palate (1 in 1687 births), and limb defects 
(1 in1943 birth). Congenital heart disorders, neural tube defects, and Down 
syndrome are the three commonest causes of mortality due to CA in that order
One in every 33 children born in the USA suffers from a birth anomaly, and 1 
in 5 deaths among infants is due to morbidities related to them [2]. Globally about 
7.9 million children are born with a major birth malformation every year, and CA 
is the fourth leading cause of neonatal death worldwide [3]. The annual cost of 
hospitalization due to congenital malformations is reported to be $22.9 billion in the 
USA [4]. The cost of care of infants suffering from CA is relatively higher than any 
Figure 1. 
Infant mortality per 100,000 live births in the United States.
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other childhood morbidity. While 3.0% of all hospitalizations are attributed to birth 
anomalies, the diagnosis accounts for 5.2% of total hospital costs. The cost of care 
is highest in the children who are <1 year of age and accounts for 35.0% of the total 
hospitalization costs among the pediatric population. The congenital cardiac defects 
register the highest CA-associated hospitalization costs across all age groups at 26.6%, 
while only 14.0% of CA–associated hospitalizations are attributed to this system.
2. Abnormal morphogenesis
Normal morphogenesis is a systematic process that involves a combination of 
several simultaneously or sequentially occurring histo-physiological activities at 
the cellular and molecular levels. These processes are cell migration, aggregation 
of identical cell types, the interaction between neighboring tissues, controlled 
cell death, mechanical forces, and hormonal effects. The congenital anomaly is an 
outcome of abnormal morphogenesis and is defined as any structural or functional 
anomaly detected at birth that interferes with the performance or appearance of 
the subject. The etiopathogenesis of congenital anomalies is broadly divided into 
genetic and non-genetic groups, and the latter one is classified into several major 
sub-categories. Some anomalies remain idiopathic in etiopathogenesis, and oth-
ers may be multifactorial, i.e., have both genetic and environmental influences. 
Congenital anomalies are categorized as major and minor as per their clinical impli-
cations. While major anomalies have significant adverse medical consequences, 
minor malformations may be of cosmetic significance only. The prevalence of major 
malformations is reported to range from 2 to 4 percent according to the population 
studied, while minor anomalies may be as high as 35% in certain populations [5]. 
The presence of 3 or more minor malformations is associated with an increased risk 
of a major anomaly or syndrome. Major anomalies are generally the consequence of 
molecular defects that interfere with normal morphogenesis processes like apop-
tosis, intracellular signaling, migration of neural crest derivatives, and chromatin 
remodeling. Some of the genes (e,g. Homeobox genes in Synpolydactyly, microph-
thalmia, and holoprosencephaly), transcription factors (e.g., deletions of T-box 
1 in Conotruncal heart defects of DiGeorge syndrome), fibroblast growth factor 
receptors (in Craniosynostoses syndromes), and enzyme defects (such as choles-
terol biosynthesis leading to Smith-Lemli-Opitz syndrome) have been identified as 
etiopathogenic factors for specific major malformations.
2.1 Patterns of abnormal phenotypes
Abnormal morphogenesis may manifest in various forms at the macroscopic and 
microscopic levels [6]. Following are some of the common patterns and terminolo-
gies used in the description of an abnormal phenotype.
• Anomaly is defined as a significant morphological or anatomic variation in 
the phenotype from the standard reference population. The difference may 
be macroscopic or microscopic. Anomalies are categorized into major and 
minor. Major anomalies have significant adverse implications in functional, 
anatomical, psychological, social, or cosmetic wellbeing, and minor anomalies 
are variants with no significant medical or major cosmetic consequences. The 
presence of three or more minor anomalies suggests significant defects in mor-
phogenesis. Even though detected in only 0.5% of births, almost 90% of such 
cases have ≥1 major anomaly and might eventually end up with the diagnosis 
of some associations or syndrome.
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• Malformation is an inherently non-progressive morphologic anomaly brought 
about primarily by an intrinsic error in the developmental process at the 
cellular or molecular levels of an organ or a body part. Malformations may be 
isolated, or part of a syndrome and are causally heterogeneous. The aberration 
can happen due to gene mutations, exposure to teratogens, or a combination of 
the two. For example, the limb anomaly in Holt–Oram syndrome is genetic in 
origin, whereas in thalidomide embryopathy, it is due to teratogenic exposure.
• Deformation alludes to a distortion of the shape or size in an otherwise normal 
body part of a normally developing or developed fetus, caused by some aber-
rant extrinsic or intrinsic mechanical forces. Examples include craniofacial 
asymmetry, arthrogryposis, and metatarsus adductus (Figure 2). Uterine 
anomalies and abnormal fetal positions are important setups for the generation 
of fetal deformation. Deformations are causally heterogeneous and may result 
in the loss of alignment or abnormal positioning and distorted configuration. 
Deformations are generally reversible after birth but may be difficult if the 
transduction of abnormal mechanical forces is prolonged. Deformation gener-
ally happens after organogenesis, but if in early gestation, it may permanently 
alter the structural relationships. If mechanical transduction happens during 
embryogenesis, anomalies in the neural tube, tendons, and joints may be 
produced.
• Disruption is defined as a static morphologic abnormality brought about 
in-utero by some destructive mechanical forces acting upon an otherwise 
normally developing or developed fetal tissue or physical part. It results in the 
destruction of the involved body part and may cause the developmental arrest 
of the adjacent tissues, thereby leading to a secondary malformation (Figure 3). 
It can be an initial event in a sequence of events if it occurs early in gestation. 
It is causally heterogeneous and may be isolated or part of a syndrome or other 
broader patterns. A disruption can impart a particularly distinctive appearance 
because of the loss of tissue and aberrant differentiation of adjacent tissues 
with or without the production of adhesions. The process results in cell death 
and tissue destruction, and the mechanisms may include vascular compromise, 
anoxia, teratogens exposure, infections, or mechanical forces. Clinical enti-
ties such as missing digits or limbs are examples of disruption. The process 
Figure 2. 
Metatarsus adductus as an example of deformation due to intrauterine positioning or space constraints.
Congenital Anomalies in Newborn Infants - Clinical and Etiopathological Perspectives
4
characteristically affects several tissue types in a specific anatomical region, and 
the phenotypic abnormalities may cross cell lines of embryonic development. 
Some pathological developmental processes can cause both disruption and 
deformation. For example, constriction rings at the tip of a finger associated 
with bands (fibrous strands of tissue) are often used as an example of disrup-
tion, but fibrous bands can also cause deformation. "Amniotic bands" encircling 
a limb are one possible mechanism of disruption of an extremity.
• Dysplasia is an abnormality in the growth and development of cell or tissue 
histology, or the anatomical structure or physiological function resulting from 
such growth. Tumors and malignancies are the results of a dysplasia process. 
Dysplasia can be isolated in occurrence or be a part of broader patterns. 
Dysplasias are causally heterogeneous and can be triggered by genetic factors, 
teratogens exposure, or metabolic disorders. The presentation may involve one 
or multiple germ layers and single or multiple organs. It may be localized or 
generalized; unilateral or bilateral; focal or multifocal; benign, malignant or 
premalignant; static or progressive; or evanescent. Dysplasia may be associated 
with malformations. It can happen at the cellular level (microscopic), examples 
being BPD and fibrous epithelial dysplasia, or in organs (macroscopic) such 
as renal dysplasia. It may be a dynamic or an ongoing process and maybe 
widespread or confined to a single organ. It can occur both prenatally and 
postnatally.
• Sequence refers to the phenomenon of a single or multiple morphological 
anomalies cascading from a single primary anomaly, which might be mal-
formation, disruption, dysplasia, or deformation in character. The resultant 
anomaly is not an essential and direct derivation of the primary cause, as 
happens in genetic aberration cases. A sequence can occur as an isolated 
phenomenon or as a component manifestation of broader patterns such as 
syndromes; and like malformations is causally heterogeneous. A common 
example is the Pierre Robin sequence, in which a small mandible, the primary 
anatomical defect, leads to protruding tongue, which in turn may interfere 
with the palatal closure and consequently create a cleft palate. In describing 
a sequence, sometimes it may be difficult to distinguish between the primary 
and the consequential effects.
• Association is defined as a pattern of morphological anomalies which are not 
causally related but occur together more often than would be expected by 
Figure 3. 
Amputation of digits with a constricting amniotic band as an example of disruption.
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chance only. Some associations may be syndromes with overlapping features. 
Such cases may eventually be identified to have a pathological etiology and 
then moved to the category of a syndrome. In the case of CHARGE associa-
tion, after the causative gene was identified, the nomenclature was changed to 
CHARGE syndrome.
• A syndrome is a combination of causally but not necessarily pathogenically 
related anomalies that are characterized into a specific condition. The anoma-
lies can be malformations, deformations, disruptions, sequences or dysplasia, 
major or minor, or functional, such as those affecting the neurological, cogni-
tive, sensory, or behavioral performances.
2.2 Anomalies of genotype
Genetically determined and inheritable diseases can occur as a result of chromo-
somal or single-gene (Mendelian) abnormalities. Some of the inherited disorders 
are multifactorial in origin, and others may be attributed to defects in the mito-
chondrial chromosomes [7]. The last category has the highest phenotypic variability 
due to heteroplasmy and the fact that mitochondrial DNA has high incidence of 
mutation [8]. As the mitochondrial DNA is inherited from the mother, the genetic 
transmission occurs from the affected mother only. Single gene disorders (SGD) 
may present with autosomal dominant, autosomal recessive, X-linked recessive, and 
X-linked dominant patterns of inheritance. Cystic fibrosis is the commonest SGD 
reported in the Caucasian population.
Chromosomal anomalies may result from maldistribution (numerical aberra-
tions) or rearrangements (structural abnormalities) of chromosomes. A numeri-
cal error in the array of chromosomes is termed aneuploidy, which presents as 
polyploidy with an addition or monosomy with a reduction in the number of 
chromosomes (Figure 4). Most of these conditions result from the failure of 
chromosomes to disjoin during meiosis (non-disjunction). Some of the common 
examples of aneuploidy are the trisomy syndromes or Turner and Klinefelter 
syndromes.
Structural chromosome disorders result from the breakage and rearrangement 
of segments or parts of a chromosome (Figure 5).
• Deletion refers to the loss of a piece or section of chromosomal material. If 
too small to be visualized under a microscope, it is termed microdeletion. 
Deletions can be terminal if only one break is present at the end or interstitial 
if two pieces of chromosome material are lost from within the chromosome. 
There is only one copy of a particular chromosome segment instead of the 
usual two copies in deletion syndromes.
• Duplication presents with an extra copy of a segment of a chromosome. So 
there are three copies of a particular chromosome segment instead of the 
usual two.
• Mutation indicates a change in the DNA sequence that leads to a change in 
its function. A mutation may be silent (no overt clinical signs or symptoms 
as amino acids may be encoded on different codons); missense (the codon is 
changed by a new nucleotide); nonsense (new nucleotide changes the codon 
to a STOP codon so that the mRNA translation is stopped) or splice-site when 
mutation at splice site prevents removal of an intron.
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Figure 5. 
Common structural chromosomal anomalies resulting in abnormal genotype.
• Translocation happens when genetic material is exchanged between two chro-
mosomes. It may be balanced with no gain or loss of DNA and no anomalies or 
unbalanced when the process results in gain or loss of chromosomal material. 
Even though there may not be any phenotypical anomalies, balanced transloca-
tions might have implications for the offsprings of the patient.
• Reciprocal translocation is an anomaly in which the phenotype is normal 
despite the break and exchange of material between 2 chromosomes.
• Robertsonian translocation is another example in which the phenotype may be 
normal. It involves only selected chromosomes, such as 13,14,15,21,22. In this 
anomaly, the short arm is lost, and long arms fuse at the centromere.
• Inversion is described when a piece of a chromosome breaks at two places and 
then is reinserted in the opposite direction. Inversions may be paracentric if it 
does not involve centromere or pericentric if the centromere is involved.
Figure 4. 
An example of aneuploidy with Trisomy 21 showing an extra chromosome 21.
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• Isochromosomes result from abnormal mitosis in which a break at centromere 
results in two short (p) arms or two long (q) arms from the same side, both 
carrying identical genes.
• Dicentric chromosomes are defined as the abnormal fusion of two chromo-
some pieces, both having a centromere.
• Ring chromosomes form when the deletion happens at the ends of both 
arms of the same chromosome and the remaining chromosome join, mak-
ing a ring-like shape. The chromosomes may be eventually lost, resulting in 
monosomy.
3. Evaluation of an infant with congenital malformations
The clinical evaluation of a child born with an anomaly begins with a detailed 
history of the extended family and a comprehensive history of the parents, 
with special attention to age, gravidity, parity, miscarriages, pregnancy-related 
complications, history of prescription drugs intake, substance abuse, significant 
illnesses and consanguinity among others. This is followed by a thorough physi-
cal examination, which should consist of a detailed assessment of craniofacial 
profile for dysmorphology and of individual organ systems, including the 
vertebral column, extremities, and skin. The histopathological features of the 
placenta and umbilical cord should be noted. The next step includes the perfor-
mance of specific diagnostic tests, which are selected on the basis of the results 
of history and physical findings and should be individualized according to the 
case. Referral to a geneticist is indicated if one major or more than two minor 
anomalies are present.
3.1 Physical examination
The physical examination starts with the standard measurements of weight, 
length, and head circumference. In infants suffering from short stature, skeletal 
dysplasia, or suspected Marfan syndrome, arm span and lower segment/upper 
segment ratio are useful variables to note. The following is a list of specific 
features and characteristics to seek during the general evaluation of an infant 
with congenital malformations: midface hypoplasia; prognathism , retrognathia, 
micrognathia; facial asymmetry; hypertelorism, hypotelorism; ophthalmople-
gia; esotropia, exotropia; cataract; nystagmus; ptosis; inner canthal distance, 
outer canthal distance, interpupillary distance; palpebral fissures length; 
long, anteriorly or posteriorly rotated ears; low set ears; microtia; prominent, 
bulbous nasal tip; slit appearance of nose; anteverted nares; long or smooth 
philtrum; macrostomia, microstomia, high arched palate, cleft lip/palate; cleft 
uvula,; macroglossia, protruding tongue ; wide or short neck , neck webbing 
; pectus excavatum or pectus carinatum; wide-spaced nipples; scoliosis, deep 
sacral dimple, sacral hair tuft, sacral tag; sirenomelia; limited range of motion 
of extremities, contracture; polydactyly syndactyly, brachydactyly, arachno-
dactyly, broad thumbs and toes; clubfoot; breast development; Tanner staging. 
Ambiguous genitalia; micropenis; cryptorchidism; hypoplasia of labia or vaginal 
hypoplasia/atresia, sparse or excess body hair; abnormally light hair; skin hyper-
pigmentation /hypopigmentation; albinism; nail dystrophy. In addition to these, 
a detailed systemic evaluation is an essential and integral part of the physical 
examination of a child born with anomalies. The physical examination should be 
standardized and performed by a trained dysmorphologist [9].
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3.2 Specific tests and laboratory investigations
As mentioned earlier, the need and selection of testing depend upon the 
results of the history and physical examination. Specific tests commonly include 
computed tomography (CT), and magnetic resonance imaging (MRI) scans of 
the central nervous system (CNS), echocardiogram, skeletal survey, and autopsy 
if the patient expires. An ultrasound evaluation of the genitourinary system is 
indicated in the conditions of ambiguous genitalia in order to detect the presence 
of abdominal gonads and uterus and to assess the anatomy of kidneys, ureters, 
bladder, and testicles. Fundoscopy may be done to detect ocular anomalies, such as 
retinal colobomas, optic disc defects, and chorioretinitis. TORCH infections and 
other significant viral infections should be ruled out by performing specific tests as 
clinically indicated.
3.3 Tests for suspected genetic disorders
The selection of chromosomal studies is guided by the clinical presentation. 
Exome sequencing helps in the identification of rare single-gene disorders and 
is indicated in the conditions of multiple, complex congenital anomalies with 
no otherwise identified genetic defect. Molecular-based chromosome microar-
ray studies (array comparative genomic hybridization or aCGH) are utilized to 
diagnose microdeletions. aCGH is the first line of testing in children with multiple 
anomalies and intellectual disabilities [10]. It has now replaced Giemsa banding 
karyotype (G-banding) and fluorescent in situ hybridization (FISH) studies. aCGH 
testing may be indicated in the following conditions: one or more major anomalies, 
three or more minor anomalies, unexplained intellectual deficiency, dysmorphism 
with or without tone and intellectual deficits, unexplained failure to thrive, family 
history of birth defects, and multiple miscarriages [11]. The FISH test may be used 
to confirm a microdeletion or microduplication detected by aCGH and is generally 
used in the prenatal screening of cells in amniotic fluid. In the conditions of consan-
guinity or suspected uniparental disomy (UPD), where the chromosome material is 
coming from one parent only, single nucleotide polymorphisms (SNPs) is indicated. 
Another test, called Whole-exome sequencing (WES), is used in children with 
multiple structural anomalies associated with intellectual disability and/or seizures 
[12]. This technique uses next-generation sequencing and can simultaneously 
analyze the coding regions of almost 19,000 to 20,000 genes. While WES cannot 
be used for the detection of microdeletions or microduplications, whole-genome 
sequencing (WGS) can detect larger deletions or duplications, as well as triple 
repeat expansions; and mutations in deep intronic regions, regulatory regions that 
are outside of the coding regions, and untranslated gene regions.
Some genetic disorders are metabolic in origin and require metabolic studies in 
addition to the genetic workup. These studies include tests for blood amino acids and 
urine organic acids, specific tests for the peroxisomal disorder, including liver biopsy 
in certain conditions, assessment of serum cholesterol precursors, and lactic acid and 
pyruvic acid levels in the blood and cerebrospinal fluid, among others. Metabolomics 
uses mass spectrometry to detect and quantify small molecules in plasma for the diag-
nosis of inborn errors of metabolism. This procedure scientifically studies the small 
molecule substrates (<1.5 kDa) called metabolites which are products of the bio-
chemical processes in cellular metabolism. One of the cellular functions that entails 
mRNA, gene expression, and proteomic analyses leads to the release of gene products 
in the cell. Metabolomics meets the challenge of systems biology and functional 
genomics by integrating genomics, transcriptomic and proteomic information. Thus 
metabolomic information provides a better understanding of cellular biology.
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3.4 Clinical care and outcome
The clinical care of a child is done via a multi-disciplinary approach and involves 
a team of pediatrician, geneticist, neurologist, cardiologist, surgeon, orthopedics 
surgeon, dermatologist, infectious disease specialist, and other specialties as 
indicated. The involvement of the social worker is important for family and social 
support. The natural course, complications, and eventual clinical outcomes depend 
on the anomaly and may range from inconsequential to severe. Some CAs are lethal 
in nature. Death from lethal anomalies can occur in-utero, at birth, during the 
perinatal period, or later at various stages of life. Others may have a normal span of 
life. The quality of life also is widely variable depending on the disorder.
4. Risk assessment of congenital anomalies
The assessment of risks for CA may not always be possible due to the lack of refer-
able evidence and information. The known recurrence risks of some of the heritable 
disorders are presented in Table 1. Some of the risk factors for CA are well docu-
mented, such as parental age, subjects’ gender, geographical location and exposure 
to drugs or toxins etc. Advanced maternal age is extensively reported to be associated 
with aneuploidies, such as trisomy 21, 13, and 18 and Klinefelter syndrome. Advanced 
maternal age has also been associated with non-chromosomal genitourinary anomalies, 
Disease Condition Recurrence risk
Pyloric stenosis Mother affected 19% risk for male, 7% for female 
offspring
Father affected 5.5% risk for male, 2.4% for female
1 child affected 4% risk to next male 2.4% to female 
child
Cleft lip Unaffected parents, 1 child affected 4.5% risk for next child
1 parent and 1 child affected 10% risk to next child
Cleft palate 1 child affected 2.6% risk to sibling
Congenital hip dysplasia 1 affected child 0.5% risk for male 6.3% for female 
child
Cardiac defects 1 child affected 3.4% risk for next child
2 children affected 10% risk for next child
Neural tube defects 1 child affected 3.5% risk to next child
Trisomy 21 Mother with balanced translocation 10–15% risk for sibling
Father with balanced translocation 5% risk for sibling
1 child affected, no parental 
translocation
1% risk for sibling
Hirschsprung’s disease 1 child affected 3–5% risk for next child
Club foot 1 affected child 2% risk if 1st child is male, 5% if 
female
1 parent and 1 child affected 25% risk to next child
Table 1. 
Recurrence risk of certain malformations. (adapted from Jones KL, Smiths recognizable patterns of human 
malformations, 5th edition, WB Saunders, Philadelphia, 1997; and Neonatology Review, 2nd edition,  
D. Brodsky & C. Martin, Hanley and Belfus Inc.2003.
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as well as hips and feet deformities [13]. Advanced paternal age is associated with an 
increased incidence of de novo DNA mutations and chromosomal aberrations in the 
sperm, which may lead to miscarriage or genotypical and/or phenotypical anomalies in 
the fetus [14]. Like advanced maternal age, trisomy 21 is documented to be associated 
with advanced paternal age as well [15]. Other disorders reported to occur more com-
monly with advanced paternal age are achondroplasia, osteogenesis imperfecta, and 
some syndromes such as Apert, Waardenburg, Marfan, and Treacher Collins.
Green et al. have reported that the risks for cleft palate, diaphragmatic hernia, 
right ventricular outflow tract obstruction, pulmonary valve stenosis, anomalous 
pulmonary venous return, cataract, aortic coarctation, encephalocele, esophageal 
atresia, and multiple complex defects in the offsprings are enhanced with each unit 
year increase in the paternal age [14]. It is noteworthy that the effects of paternal 
age might vary in tandem with maternal age. While young maternal and paternal 
age are identified as independent risk factors for gastroschisis, young paternal age 
can become a risk factor for gastroschisis again if the mother’s age exceeds 35 years. 
Omphalocele, spina bifida, orofacial clefts, and septal heart defects display associa-
tions with parental mating, which involves advanced paternal and young maternal 
age, and also between a young father and mother of advanced age.
Some diseases exhibit gender preferences [16, 17]. The diseases known to occur 
more commonly in males are pyloric stenosis, Hirschsprung’s disease, imperforate 
anus, club foot, unilateral multicystic dysplastic kidney; cleft lip and palate, Poland 
sequence, ventricular septal defect, transposition of great vessels, aortic coarctation, 
hypoplastic left heart syndrome, subdiaphragmatic total anomalous pulmonary 
venous return, and pulmonic stenosis and atresia. Disorders identified to be more 
common in females are choanal atresia, choledochal cyst, congenital hip dysplasia, 
ureterocele, Trisomy 18, atrial septal defect, patent ductus arteriosus, anencephaly, 
meningomyelocele and congenital hypothyroidism. In a recent study of 12,795 
cases with CA, male fetuses were found to be more susceptible to birth defects than 
females, however, with significant heterogeneity in the subtypes [16]. Sex organ 
anomalies are reported to be 8.5 times more common, and GIT defects 55%, whereas 
urinary tract anomalies 62% more prevalent in males than in females. Overall, the 
prevalence of major CA in males is 3.9% compared to 2.8% in females [17].
4.1 Calculation of carrier frequency and recurrence risk in a population
The Hardy-Weinberg equilibrium is utilized to predict carrier frequency in a 
given population and to calculate recurrence risk. The calculation assumes that the 
mating is random and there are no new mutations or natural selections.
4.1.1 Calculation of carrier frequency
Example: Normal gene frequency=P; Abnormal gene frequency =Q; P+Q =1 (i.e. 
100%); 2PQ =carrier frequency; P2= normal, non-carrier frequency; Q2 = affected 
frequency.
Let us take the example of cystic fibrosis (CF), an autosomal recessive disease. 
The disease frequency of the morbidity is 1 in 2500 Caucasian births. I.e., Q2 = 
1/2500; therefore Q= 1/50. We know that P+Q=1. So P=1-Q or 1-1/50 = 49/50 ~ 1. 
Therefore 2PQ (carrier frequency) = 2 * 1 * 1/50 = 1/25.
4.1.2 Calculation of recurrence risk of CF
Example: a pregnant woman has a sister with CF. What are the chances of her 
having an affected child?
11
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The Father’s risk of being a carrier is 1/25, while the mother’s chances of being 
a carrier are 2/3 as both of her parents are carriers. The chance of the offspring 
getting the gene from each parent is ¼. Therefore the chances of the child being 
affected by CF are 1/25X2/3X1/4=1/150.
5. Summary
Congenital anomalies are a heterogeneous group of disorders of abnormal 
morphogenesis, which present at birth and carry widely variable implications for 
morbidity and mortality. The basics of incidence, pathogenesis, and risk assess-
ments of CA are discussed in this section.
© 2021 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
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